What does MEDCOLAB do?

MEDCOLAB is filed with the CBE under the catch-all “Niet-gespecialiseerde groothandel”, a code that says little about what the company actually does. Private Limited, started on 29 October 1999, 1 establishment.

What is the address of MEDCOLAB?

The registered office of MEDCOLAB is located at Joseph Bensstraat 81, 1180 Ukkel.

Is MEDCOLAB still active?

Yes. According to the CBE (31 October 2026) MEDCOLAB is active, legal situation “Normale toestand”, started on 29 October 1999.

Is MEDCOLAB registered on Peppol?

Yes, MEDCOLAB is registered on the Peppol network with ID 0208:0467172982.

What is the enterprise number of MEDCOLAB?

The enterprise number of MEDCOLAB is BE0467172982.

When was MEDCOLAB founded?

MEDCOLAB was founded on 29 October 1999.

Who are the directors of MEDCOLAB?

According to the 2025 annual accounts, the directors of MEDCOLAB are: William Vandenbulcke, Antoon Vandenbulcke.

Is MEDCOLAB a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 October 1999; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MEDCOLAB make in 2025?

MEDCOLAB posted a profit after taxes of € 66,042 in financial year 2025.

What is the revenue of MEDCOLAB?

As a small company, MEDCOLAB is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 467,488.

How much does an employee at MEDCOLAB earn?

The average wage cost per full-time employee at MEDCOLAB was € 222,300 in 2025: staff costs of € 222,272 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does MEDCOLAB have?

According to the 2025 annual accounts, MEDCOLAB has 1 full-time equivalents (FTE).

MEDCOLAB (Private Limited) - Ukkel - BE0467172982

Dossier MEDCOLAB, printed on 31 October 2026 from databakkes.be/en/0467172982/medcolab. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDCOLAB from Ukkel, company number BE0467172982, closed financial year 2025 with a result of € 66,042 after tax. For that financial year MEDCOLAB recorded a gross margin of € 467,488 and equity of € 1.5 million. Compared with financial year 2024, the result moved from € 21,360 to € 66,042. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.

What it is worth Growing

€ 1.5 million

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 66,042

▲ 209% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 92,730

▲ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.4 million.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 222,272

▲ 1% vs 2024

€ 222,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 23,285

▼ 31% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 73 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.5 million

▲ 1% vs 2024

€ 20,911 is repaid this year. At this pace the long-term loan is gone in ≈ 73 years.

Owed to suppliers

€ 1,453

▼ 71% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 30,965

▼ 45% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 515,009 Gross margin 2022: € 515,009 First fiscal year in the series	€ 373,078 Gross margin 2023: € 373,078 ▼ 28% vs 2022 (€ 515,009) Unfavourable step	€ 429,852 Gross margin 2024: € 429,852 ▲ 15% vs 2023 (€ 373,078) Favourable step	€ 467,488 Gross margin 2025: € 467,488 ▲ 9% vs 2024 (€ 429,852) Favourable step	▲ 9%
Profit after taxes	€ 189,587 Profit after taxes 2022: € 189,587 First fiscal year in the series	€ 37,186 Profit after taxes 2023: € 37,186 ▼ 80% vs 2022 (€ 189,587) Unfavourable step	€ 21,360 Profit after taxes 2024: € 21,360 ▼ 43% vs 2023 (€ 37,186) Unfavourable step	€ 66,042 Profit after taxes 2025: € 66,042 ▲ 209% vs 2024 (€ 21,360) Favourable step	▲ 209%
Equity	€ 1,598,777 Equity 2022: € 1,598,777 First fiscal year in the series	€ 1,635,964 Equity 2023: € 1,635,964 ▲ 2% vs 2022 (€ 1,598,777) Favourable step	€ 1,469,911 Equity 2024: € 1,469,911 ▼ 10% vs 2023 (€ 1,635,964) Unfavourable step	€ 1,535,953 Equity 2025: € 1,535,953 ▲ 4% vs 2024 (€ 1,469,911) Favourable step	▲ 4%
Total debts	€ 1,416,225 Total debts 2022: € 1,416,225 First fiscal year in the series	€ 1,298,272 Total debts 2023: € 1,298,272 ▼ 8% vs 2022 (€ 1,416,225) Favourable step	€ 1,775,668 Total debts 2024: € 1,775,668 ▲ 37% vs 2023 (€ 1,298,272) Unfavourable step	€ 1,720,208 Total debts 2025: € 1,720,208 ▼ 3% vs 2024 (€ 1,775,668) Favourable step	▼ 3%
Cash	€ 103,241 Cash 2022: € 103,241 First fiscal year in the series	€ 100,650 Cash 2023: € 100,650 ▼ 3% vs 2022 (€ 103,241) Unfavourable step	€ 87,737 Cash 2024: € 87,737 ▼ 13% vs 2023 (€ 100,650) Unfavourable step	€ 92,730 Cash 2025: € 92,730 ▲ 6% vs 2024 (€ 87,737) Favourable step	▲ 6%
Land & buildings	€ 2,746,546 Land & buildings 2022: € 2,746,546 First fiscal year in the series	€ 2,683,102 Land & buildings 2023: € 2,683,102 ▼ 2% vs 2022 (€ 2,746,546) Unchanged	€ 2,881,342 Land & buildings 2024: € 2,881,342 ▲ 7% vs 2023 (€ 2,683,102) Unchanged	€ 2,797,536 Land & buildings 2025: € 2,797,536 ▼ 3% vs 2024 (€ 2,881,342) Unchanged	▼ 3%
Retained profit	€ 1,491,685 Retained profit 2022: € 1,491,685 First fiscal year in the series	€ 1,528,872 Retained profit 2023: € 1,528,872 ▲ 2% vs 2022 (€ 1,491,685) Favourable step	€ 1,362,819 Retained profit 2024: € 1,362,819 ▼ 11% vs 2023 (€ 1,528,872) Unfavourable step	€ 1,428,861 Retained profit 2025: € 1,428,861 ▲ 5% vs 2024 (€ 1,362,819) Favourable step	▲ 5%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 187,413 Dividend 2024: € 187,413 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 187,413) Unchanged	▼ 100%
Bank debt	€ 564,480 Bank debt 2022: € 564,480 First fiscal year in the series	€ 544,485 Bank debt 2023: € 544,485 ▼ 4% vs 2022 (€ 564,480) Favourable step	€ 1,514,055 Bank debt 2024: € 1,514,055 ▲ 178% vs 2023 (€ 544,485) Unfavourable step	€ 1,528,438 Bank debt 2025: € 1,528,438 ▲ 1% vs 2024 (€ 1,514,055) Unfavourable step	▲ 1%
Balance sheet total	€ 3,015,003 Balance sheet total 2022: € 3,015,003 First fiscal year in the series	€ 2,934,235 Balance sheet total 2023: € 2,934,235 ▼ 3% vs 2022 (€ 3,015,003) Unchanged	€ 3,245,578 Balance sheet total 2024: € 3,245,578 ▲ 11% vs 2023 (€ 2,934,235) Unchanged	€ 3,256,161 Balance sheet total 2025: € 3,256,161 Unchanged (€ 3,245,578) Unchanged
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	1 Employees (FTE) 2023: 1 Unchanged (1) Unchanged	1 Employees (FTE) 2024: 1 Unchanged (1) Unchanged	1 Employees (FTE) 2025: 1 Unchanged (1) Unchanged

Key figures of MEDCOLAB, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDCOLAB?

What happened at MEDCOLAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 9, 2026 New annual accounts for financial year 2025: profit of € 66,042 (▲ 209% vs 2024). Source: NBB ↗
2024 William Vandenbulcke became a director. NBB
May 3, 2002 New establishment in Ukkel. KBO
2000 Antoon Vandenbulcke became a director. NBB
Oct 29, 1999 Start of the company according to the CBE. KBO

In short

From € 189,587 profit in 2022 to € 66,042 profit in 2025.

Paid € 116,706 in corporate taxes since 2022.

Best year ever: 2022, with € 189,587 profit.

On average € 467,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Antoon Vandenbulcke 20%

MEDCOLAB

Behind MEDCOLAB are William Vandenbulcke and Antoon Vandenbulcke. The shares are held by Antoon Vandenbulcke (20%).

Directors

According to the 2025 annual accounts

William Vandenbulcke

Director

Also active at: AKILA CONSULTING

since 2024

Antoon Vandenbulcke

Director

Owns 20% directly

Also active at: TOBUFAR

since 2000

Shareholders

Antoon Vandenbulcke · director

20%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Joseph Bensstraat 81

1180 Ukkel

2.094.686.987

Joseph Bensstraat 83 A

1180 Ukkel

Active since 3 May 2002

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0467.172.982

VAT number

BE 0467.172.982

Registered office

Joseph Bensstraat 81, 1180 Ukkel

Names & denominations

MEDCOLAB

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

29 October 1999

Peppol

Active · Active since 13 Jan 2026

Activities · NACE

Niet-gespecialiseerde groothandel

Handelsbemiddeling in de groothandel in voedings- en genotmiddelen

Handelsbemiddeling in voedings- en genotmiddelen

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDCOLAB

Financials

What happened to MEDCOLAB?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions